Therapeutic Solutions International Inc 주요 수익원은 Immune Modulation이며, 최신 수익 발표에서 수익은 98,994입니다. 지역별로는 United States이 Therapeutic Solutions International Inc의 주요 시장이며, 수익은 98,994입니다.
Magnolia Bancorp Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Therapeutic Solutions International Inc의 순손실은 $-2입니다.
Magnolia Bancorp Inc에 부채가 있나요?
예, Therapeutic Solutions International Inc의 부채는 2입니다.
Magnolia Bancorp Inc의 발행 주식은 몇 주인가요?
Therapeutic Solutions International Inc의 총 발행 주식은 3,802.66주입니다.
주요 통계
이전 종가
$12.9
시가
$13.19
일일 범위
$13.19 - $13.49
52주 범위
$10.8 - $13.49
거래량
1.4K
평균 거래량
1.1K
배당수익률
--
EPS(TTM)
--
시가총액
$11.1M
MGNO란 무엇인가요?
Magnolia Bancorp, Inc. is a holding company, which engages in providing state-chartered banking services through its subsidiaries. The company is headquartered in Metairie, Louisiana and currently employs 8 full-time employees. The company went IPO on 2025-01-14. The Association serves the banking needs of customers in its market area, which primarily consists of Jefferson and St. Tammany Parishes in Louisiana. The Association operates from its headquarters and main banking office in Metairie, Louisiana, as well as one additional full-service branch office located in St. Tammany Parish on the north shore of Lake Pontchartrain in Mandeville, Louisiana. Its primary business activity is attracting deposits from the general public and using those funds primarily to originate one-to-four-family residential loans, residential construction loans and home equity lines of credit.